Skip to main content

IDWeek 2024 Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

427 Views

I1. Adult Vaccines

Poster Session: Adult Vaccines

(P-19) The Adjuvanted Recombinant Zoster Vaccine Is Effective in Preventing Herpes Zoster (HZ) Among Patients ≥ 50 Years of Age (YOA) With Selected Autoimmune Diseases in the United States: A Real-World Database Analysis (2018–2021)

Thursday, October 17, 2024

12:15 PM – 1:30 PM US PT

Location: Halls JK

Co-Author(s)

DC

Dagna Constenla, PhD, MPA, MPhil, BA

GSK
Rockville, Maryland, United States

Co-Author(s)

GL

Germain Lonnet, MSc.

GSK
Wavre, Brabant Wallon, Belgium
EA

Emmanuel Aris, PhD

Lead Real World Data & Analytics
GSK
Wavre, Brabant Wallon, Belgium
NS

Nathalie Servotte, PhD

GSK
Wavre, Brabant Wallon, Belgium
RR

Ramsanjay RK, B.Tech Mechanical Engineering

GSK
Bengaluru, Karnataka, India
AM

Agnes Mwakingwe-Omar, MD, PhD

GSK, Rockville, MD, USA
Rockville, Maryland, United States

Presenting Author(s)

Huifeng Yun, MD, PhD

Epidemiologist
GSK
Rockville, Maryland, United States